Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
45 hedge funds and large institutions have $13.8M invested in Checkpoint Therapeutics in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 5 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 6
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
62% more capital invested
Capital invested by funds: $8.54M → $13.8M (+$5.28M)
10% more funds holding
Funds holding: 41 → 45 (+4)
0.28% more ownership
Funds ownership: 1.18% → 1.45% (+0.28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.1M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$216K |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$182K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$152K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$174K |
| 2 |
Goldman Sachs
New York
|
-$35K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$26.6K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$21K |
CKPT Hedge Fund Activity: Q2 2020 in Review
45 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2020, worth a combined $13.8M — up 62% from $8.54M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CKPT positions and 5 closed out — a net gain of 4 holders — while 20 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $1.1M. The largest seller was Bank of America, cutting an estimated $174K.
- 45 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2020, up from 41 in Q1 2020.
- Funds reported $13.8M of Checkpoint Therapeutics stock for Q2 2020, up 62% quarter-over-quarter.
- 9 funds opened new Checkpoint Therapeutics positions in Q2 2020 and 5 closed out, a net change of +4 holders.
- The largest Checkpoint Therapeutics buyer in Q2 2020 was BlackRock, an estimated $1.1M added.
- The largest Checkpoint Therapeutics seller in Q2 2020 was Bank of America, an estimated $174K sold.
Based on aggregated 13F filings for Q2 2020.